NXTCL — NextCell Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK126.39m
- SEK94.06m
- SEK13.70m
Brief: Nextcell Pharma: ProTrans Stem Cells Approved For Clinical Trials On COVID-19 Patients
Brief: NextCell Pharma: ProTrans Shows Significant Effect In Diabetes
Brief: Nextcell Announces Eurostars Grant For Developing An Innovative Cell Therapy Production Platform
Brief: Nextcell Pharma Q3 Pre-Tax Loss Widens To SEK 4.8 Mln
Brief: NextCell Pharma To Change List To Nasdaq First North
Brief: NextCell Pharma Resolves Fully Guaranteed Rights Issue Of About SEK 25.1 Million
Brief: NextCell In Discussions About Patients With COVID-19
Brief: NextCell Pharma Q1 Operating Profit Up At SEK 1 222 087
Brief: NextCell Pharma: Promising Results From Stem Cell Study With ProTrans
Brief: Nextcell Pharma Q4 Pre-Tax Loss Widens To SEK 8.0 Mln
Brief: NextCell Pharma Raises About SEK 24.9 Million In Rights Issue
Brief: Nextcell Pharma Enters Partnership With Bonzun Health Information
Brief: Nextcell Pharma: Anders Essen-Möller And Diamyd Medical Increases Stakes In Co
Brief: Diamyd Medical Fully Subscribes To Its Pro Rata Share In NextCell Pharma's Rights Issue
Brief: NextCell Pharma: Discussions On Merger Between Nextcell And Idogen Suspended
Brief: NextCell Pharma Comments On Potential Merger Between NextCell Pharma And Idogen
Brief: Nextcell's Biobank Now Able To Offer Stem Cell Saving For Adults
Brief: NextCell Pharma Gets Order Of About SEK 350,000
Brief: Nextcell Pharma To Appoint Sofia Fredrikson CFO